INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 48m ago
House PTR8m ago
SEC 13F7m ago
Robinhood Chain7m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
BW
Benton Kelly WVP & CAO
SAIASAIA INC
Tax withholding
F$18K
44 sh
Feb 9, 2026Feb 10, 2026
Page 1353 of 1814
← PrevNext →
traded Feb 9, 2026
+1d
SEC Form 4

Evidence

5
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Grant or award
A—
26.5K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

5
SS
Schuller SteveSVP, Human Resources
ULCCFrontier Group Holdings, Inc.
Option exercise
M—
1,299 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,415
56 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

5
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

5
SS
Schuller SteveSVP, Human Resources
ULCCFrontier Group Holdings, Inc.
Option exercise
M—
6,055 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC Form 4

Evidence

5
SS
Schuller SteveSVP, Human Resources
ULCCFrontier Group Holdings, Inc.
Option exercise
M—
1,299 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC Form 4

Evidence

5
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
631 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC Form 4

Evidence

5
CL
Charlton Henry LEVP & Chief Commercial and Mkt
ISRGINTUITIVE SURGICAL INC
Option exercise
M—
1,077 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

5
BW
Benton Kelly WVP & CAO
SAIASAIA INC
Tax withholding
F$15K
35 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

4
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,836 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

2
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Grant or award
A—
5,893 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$8,086
3,379 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
6,894 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

1
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
5,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

0
SS
Smith Brian ScottPresident, Hearth & Home Tech
HNIHNI CORP
Option exercise · 10b5-1 plan
M—
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

0
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Option exercise · 10b5-1 plan
M—
5,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

0
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Tax withholding · 10b5-1 plan
F$79K
2,944 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

0
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Option exercise · 10b5-1 plan
M—
5,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

59
WB
Worrell BrianDirector
RALRalliant Corp
Open-market purchase
BUY$100K
2,500 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

55
MG
Moorthy GaneshDirector
RALRalliant Corp
Open-market purchase
BUY$79K
2,000 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

52
BE
Bryant Kevin E.Director
RALRalliant Corp
Open-market purchase
BUY$50K
1,250 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

51
KA
Kazmi Amir A.SVP - Chief Technology Officer
RALRalliant Corp
Open-market purchase
BUY$100K
2,545 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

44
EE
Esham William E. IIIDirector
SHBISHORE BANCSHARES INC
Open-market purchase
BUY$100K
5,000 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC Form 4

Evidence

36
FS
Filer Matthew SSVP Finance / CAO
PATKPATRICK INDUSTRIES INC
Open-market purchase
BUY$140K
1,000 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

33
CB
Carroll Charles Benner JrCOO
FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/
Open-market purchase
BUY$18K
380 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC Form 4

Evidence

33
KS
Kruzinski ShariEVP, Chief Consumer Bk Officer
WSFSWSFS FINANCIAL CORP
Open-market sale
SELL$70K
1,000 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC Form 4

Evidence

32
DE
Dunn EvanGeneral Counsel
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$6,577
688 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

31
TB
Thompson Steve BPrimeLending President and CEO
HTHHilltop Holdings Inc.
Open-market sale
SELL$360K
9,025 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

30
WJ
Wechsler James JEVP Chief Comm'l Banking Ofc
WSFSWSFS FINANCIAL CORP
Open-market sale
SELL$31K
450 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC Form 4

Evidence

28
CG
Croke GarySVP of Product and Innovation
AVNWAVIAT NETWORKS, INC.
Open-market sale
SELL$181K
6,914 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

25
MM
Mckinney Suzet MDirector
KMPRKEMPER Corp
Open-market sale
SELL$17K
504 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

24
SJ
Saunders Scott JDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC Form 4

Evidence

24
RL
Reed Michael LeeDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC Form 4

Evidence

24
PJ
Phifer Walter JChief Financial Officer
LOBLive Oak Bancshares, Inc.
Option exercise
M$84K
6,160 sh
Feb 6, 2026Feb 9, 2026
traded Feb 6, 2026
+3dSEC Form 4

Evidence

24
SH
Smith J. Henry IVDirector
FBKFB Financial Corp
Grant or award
A—
1,065 sh
Jul 2, 2025Feb 9, 2026
traded Jul 2, 2025
+222dSEC Form 4

Evidence

24
GY
Grenas Cheryl YvonneDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC Form 4

Evidence

22
LE
Lashier Mark EDirector, Chairman and CEO
PSXPhillips 66
Tax withholding
F$1.52M
9,686 sh
Feb 7, 2026Feb 9, 2026
traded Feb 7, 2026
+2dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.92M
632.9K sh
Feb 9, 2026Feb 9, 2026
traded Feb 9, 2026
+0dSEC Form 4

Evidence

21
MD
McDonald Olivia Cameron D.SVP, Chief Human Resources Off
DUKDuke Energy CORP
Grant or award
A—
2,402 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC Form 4

Evidence